TPO replied in full, Tourism Deptt never followed up *Development without direction threatens sustainability Mohinder Verma ...

The company said a total of 10,335 participants have been enrolled in the late stage trial. Each participant will be ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Hyderabad: Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received tentative ...

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...

Solid-State Materials in Pharmaceutical Chemistry: Properties, Characterization, and Applications, 2nd Edition (ISBN: 978-1-394-25444-6) offers a rigorous examination of the physical properties of ...

NASA is ramping up work on one large space telescope while also laying the groundwork for future observatories.

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

RAI calls on the government to fast-track the National Retail Policy to enhance business ease and stimulate investment growth ...

GreenWay Herbal Products, LLC today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,496,307 on December 16, 2025, covering a 1-to-1 equimolar composition of ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).